

Author: Padilla-Carlin Danielle J. Schladweiler Mette C. J. Shannahan Jonathan H. Kodavanti Urmila P. Nyska Abraham Burgoon Lyle D. Gavett Stephen H.
Publisher: Taylor & Francis Ltd
ISSN: 1087-2620
Source: Journal of Toxicology and Environmental Health, Vol.74, Iss.17, 2011-09, pp. : 1111-1132
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Increased incidences of asbestosis have been reported in workers from Libby, MT, associated with exposures to amphibole-contaminated vermiculite. In this study pulmonary and histopathological changes were investigated following Libby amphibole (LA) exposure in a rat model. Rat respirable fractions of LA and amosite (aerodynamic diameter <2.5 μm) were prepared by water elutriation. Male F344 rats were exposed to single doses of either saline (SAL), amosite (0.65 mg/rat), or LA (0.65 or 6.5 mg/rat) by intratracheal instillation. At times from 1 d to 3 mo after exposure, bronchoalveolar lavage (BAL) was performed and right and left lungs were removed for reverse-transcription polymerase chain reaction (RT-PCR) and histopathological analysis, respectively. Data indicated that 0.65 mg amosite resulted in a higher degree of pulmonary injury, inflammation, and fibrotic events than LA at the same mass dose. Exposure to either amosite or high dose LA resulted in higher levels of cellular permeability and injury, inflammatory enzymes, and iron binding proteins in both BAL fluid and lung tissue at most time points when compared to SAL controls. However, mRNA expression for some growth factors (e.g., platelet-derived growth factor [PDGF]-A and transforming growth factor [TGF]-1β), which contribute to fibrosis, were downregulated at several time points. Furthermore, histopathological examination showed notable thickening of interstitial areas surrounding the alveolar ducts and terminal bronchioles. On a mass dose basis, amosite produced a greater acute and persistent lung injury for at least 3 mo after exposure. However, further testing and analysis of LA are needed with regard to the dose metric to fully evaluate its potential fibrogenicity and carcinogenicity.
Related content


By Porter Dale W. Castranova Vince Robinson V. A. Hubbs Ann F. Mercer Robert R. Scabilloni James Goldsmith Travis Schwegler-Berry Diane Battelli Lori Washko Rita Burkhart Joe Piacitelli Chris Whitmer Michael Jones William
Journal of Toxicology and Environmental Health, Vol. 57, Iss. 1, 1999-05 ,pp. :




By Young Shih-Houng Robinson Victor A. Barger Mark Porter Dale W. Frazer David G. Castranova Vincent
Journal of Toxicology and Environmental Health, Vol. 64, Iss. 4, 2001-10 ,pp. :


By Hunter Dawn D. Castranova Vincent Stanley Charles Dey Richard D.
Journal of Toxicology and Environmental Health, Vol. 53, Iss. 8, 1998-04 ,pp. :


By Lombry Catherine Marteleur Aline Arras Mohammed Lison Dominique Louahed Jamila Renauld Jean-Christophe Préat Véronique Vanbever Rita
Pharmaceutical Research, Vol. 21, Iss. 1, 2004-01 ,pp. :